Changing the outcome of toxoplasmosis in bone marrow transplant recipients

International Journal of Antimicrobial Agents

Volumn 27, Issue 6, 2006, Pages 570-572

  Aoun, M ^a   Georgala, A ^a   Mboumi, K ^a   Lemort, M ^a   De Bruyne, J M ^a   Duchateau, V ^a   Martiat, P ^a  

^a JULES BORDET INSTITUTE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ATOVAQUONE; AZITHROMYCIN; CLARITHROMYCIN; CLINDAMYCIN; COTRIMOXAZOLE; DAPSONE; IMMUNOGLOBULIN G; PYRIMETHAMINE; PYRIMETHAMINE SULFADIAZINE; SULFONAMIDE;

ALLOGENEIC STEM CELL TRANSPLANTATION; AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE MARROW TRANSPLANTATION; DRUG RESPONSE; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIGH RISK PATIENT; HUMAN; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; LETTER; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK ASSESSMENT; SEROPREVALENCE; TOXOPLASMOSIS; TREATMENT RESPONSE;

ADULT; BONE MARROW TRANSPLANTATION; CLINDAMYCIN; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PYRIMETHAMINE; TOXOPLASMOSIS, CEREBRAL;

EID: 33646791473     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2006.04.001     Document Type: Letter

References (11)

1. Derouin F., Gluckman E., Beauvais B., et al. Toxoplasma in bone marrow transplant recipients: report of seven cases and review. Clin Infect Dis 15 (1992) 267-270
2. O'Driscoll J.C., and Holliman R.E. Toxoplasmosis and bone marrow transplantation. Rev Med Microbiol 2 (1991) 215-222
3. Martino R., Maertens J., Bretagne S., et al. Toxoplasmosis after hematopoietic stem cell transplantation. Clin Infect Dis 31 (2000) 1188-1195
4. de Medeiros B.C., de Meideros C.R., Werne B., et al. Disseminated toxoplasmosis after bone marrow transplantation: report of 9 cases. Transpl Infect Dis 3 (2001) 24-28
5. Gallino A., Maggiorini M., Kiowski W., et al. Toxoplasmosis in heart transplant recipients. Eur J Clin Microbiol Infect Dis 15 (1996) 389-393
6. Michaels M.G., Wald E.R., Fricker F.J., et al. Toxoplasmosis in pediatric recipients of heart transplants. Clin Infect Dis 14 (1992) 847-851
7. Koneru B, Anaissie E, Tricot G, et al. High incidence of and mortality from Toxoplasma gondii infections in T cell-depleted allogeneic bone marrow transplant recipients. In: Abstracts of the 39th Meeting of the American Society for Haematology; Princeton, NJ; 8 December 1997. Abstract no. 3834.
8. Martino R., Maertens J., Bretagne S., et al. Toxoplasmosis after hematopoietic stem cell transplantation. Clin Infect Dis 31 (2000) 1188-1195
9. Lin M.H., Chen T.C., Kuo T.T., et al. Real-time PCR for quantitative detection of Toxoplasma gondii. J Clin Microbiol 38 (2000) 4121-4123
10. Slavin M.A., Meyers J.D., Remington J.S., and Hackman R.C. Toxoplasma gondii infection in marrow transplant recipients: a 20 year experience. Bone Marrow Transplant 13 (1994) 549-557
11. Dannemann B., McCutchan A., Israelski D., et al. Treatment of toxoplasmic encephalitis in patients with AIDS. Ann Intern Med 116 (1992) 33-43